Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals With Type 2 Diabetes
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf172 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Huan Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fractures, Bone. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Medical Scientific Research Foundation of Guangdong Province of China, Guangdong Provincial Natural Science Foundation General Project.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Individuals with type 2 diabetes have a higher fracture risk than the general population. However, the association between joint risk factor control and fracture risk in this population remains unclear.
Objective
To investigate the extent to which joint risk factor control might attenuate the excess risk of fracture outcomes in individuals with type 2 diabetes.
Methods
We included 8935 individuals with type 2 diabetes and 35 740 matched controls without fractures at baseline from the UK Biobank (UKB), with a median follow-up of 12.1 years. Six modifiable risk factors were assessed: body mass index (BMI), physical activity, smoking, alcohol consumption, serum 25-hydroxyvitamin D (25(OH)D), and glycated hemoglobin A1c (HbA1c). Cox proportional hazards models were used to estimate associations between risk factor control and fracture risk.
Results
Controlling each additional risk factor resulted in a 14% to 26% decrease in fracture risk. Optimal control (≥5 risk factors) correlated with a 50% reduction in overall fractures (HR 0.50; 95% CI 0.33-0.75). However, a 60% reduction in hip fractures (HR 0.40; 95% CI 0.16-0.98) was observed with the control of 4 risk factors. With control of 4 or more risk factors, fracture risk in individuals with type 2 diabetes was comparable to that of nondiabetic controls, and the protective effect was stronger in men than in women.
Conclusion
Joint risk factor control was significantly linked to a reduced fracture risk, and optimal management may eliminate the excess fracture risk associated with type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Förderung
- National Natural Science Foundation of China
- Medical Scientific Research Foundation of Guangdong Province of China
- Guangdong Provincial Natural Science Foundation General Project
- NHLBI NIH HHS
- NIDDK NIH HHS
- Boston Obesity Nutrition Research Center
- United States-Israel Binational Science Foundation
- Shenzhen Science and Technology Program
Zitieren
APA
Huang, H., Cai, J., Hu, H., Cai, L., Qi, L., & Zhou, T. (2025). Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf172
Vancouver
Huang H, Cai J, Hu H, Cai L, Qi L, Zhou T. Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf172
BibTeX
@article{Huang2025,
author = {Huang, Huan and Cai, Jie and Hu, Huaying and Cai, Lishan and Qi, Lu and Zhou, Tao},
title = {Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals With Type 2 Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf172}
}
EUVIMED